La troponina I cardiaca nell'angina instabile

Translated title of the contribution: Cardiac troponin I and unstable angina

P. Musso, A. Vernocchi, A. Crippa, D. Bajardi, B. Ottello, A. Pinnavaia, G. Ronzani, G. Bergandi, A. Ravera, I. Scrocca

Research output: Contribution to journalArticle

Abstract

Background. Unstable angina implies high risk of myocardial infarction and sudden death. Increased levels of cytoplasmatic enzymes and proteins (creatine phosphokinase, MB creatine phosphokinase troponin T, etc.) were described in unstable angina, providing information about incoming major coronary events. Cardiac troponin I (cTn-I) is a structural protein inhibiting the actinomyosine ATPase; it is only found in myocardial cells. Serum titration of cTn-I has been recently introduced into clinical practice as a sensitive and specific marker of myocardial cellular necrosis. Objectives. The aim of our prospective study was to assess the presence of cTn-I in blood samples of patients with unstable angina and no signs of myocardial necrosis. Furthermore we intended to test the possible use of cTn-I in unstable angina as a prognostic marker of major coronary events on short and middle term. Methods. We studied 33 consecutive patients admitted to our CCU for unstable angina. According to unstable angina Braunwald's classification, 6 patients were included in the first class, 4 patients in the second class and 23 patients in the third class. We excluded patients with acute or recent myocardial infarction. Blood samples of all patients were obtained at the time of CCU admission and every eight hours in the first and second day. Serum cTn-I titration was performed with the sandwich immunoenzymometric method, recently introduced by Diagnostic Pasteur. Two months follow-up was carried out in order to survey major coronary events and revascularization procedures, either angioplasty or coronary artery bypass surgery. Results. No patients with unstable angina exhibited cTn-I in their blood samples; accordingly, cTn-I was not found in the first blood sample of a patient who undervent myocardial infarction during hospitalization. During the follow-up 2 patients died of myocardial infarction, 9 patients had surgical revascularization and 5 patients angioplasty. Conclusions. CTn-I is a sensitive and specific marker of myocardial necrosis. It is not found in patients with unstable angina; therefore it has no role as a prognostic marker of major coronary events.

Original languageItalian
Pages (from-to)187-195
Number of pages9
JournalMinerva Cardioangiologica
Volume44
Issue number4
Publication statusPublished - Apr 1996

Fingerprint

Troponin I
Unstable Angina
Myocardial Infarction
Necrosis
Creatine Kinase
Angioplasty
Troponin T
Sudden Death
Serum
Coronary Artery Bypass
Protein Kinases
Adenosine Triphosphatases
Hospitalization

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Musso, P., Vernocchi, A., Crippa, A., Bajardi, D., Ottello, B., Pinnavaia, A., ... Scrocca, I. (1996). La troponina I cardiaca nell'angina instabile. Minerva Cardioangiologica, 44(4), 187-195.

La troponina I cardiaca nell'angina instabile. / Musso, P.; Vernocchi, A.; Crippa, A.; Bajardi, D.; Ottello, B.; Pinnavaia, A.; Ronzani, G.; Bergandi, G.; Ravera, A.; Scrocca, I.

In: Minerva Cardioangiologica, Vol. 44, No. 4, 04.1996, p. 187-195.

Research output: Contribution to journalArticle

Musso, P, Vernocchi, A, Crippa, A, Bajardi, D, Ottello, B, Pinnavaia, A, Ronzani, G, Bergandi, G, Ravera, A & Scrocca, I 1996, 'La troponina I cardiaca nell'angina instabile', Minerva Cardioangiologica, vol. 44, no. 4, pp. 187-195.
Musso P, Vernocchi A, Crippa A, Bajardi D, Ottello B, Pinnavaia A et al. La troponina I cardiaca nell'angina instabile. Minerva Cardioangiologica. 1996 Apr;44(4):187-195.
Musso, P. ; Vernocchi, A. ; Crippa, A. ; Bajardi, D. ; Ottello, B. ; Pinnavaia, A. ; Ronzani, G. ; Bergandi, G. ; Ravera, A. ; Scrocca, I. / La troponina I cardiaca nell'angina instabile. In: Minerva Cardioangiologica. 1996 ; Vol. 44, No. 4. pp. 187-195.
@article{a87721e25d8a4fb390be0163000ccc70,
title = "La troponina I cardiaca nell'angina instabile",
abstract = "Background. Unstable angina implies high risk of myocardial infarction and sudden death. Increased levels of cytoplasmatic enzymes and proteins (creatine phosphokinase, MB creatine phosphokinase troponin T, etc.) were described in unstable angina, providing information about incoming major coronary events. Cardiac troponin I (cTn-I) is a structural protein inhibiting the actinomyosine ATPase; it is only found in myocardial cells. Serum titration of cTn-I has been recently introduced into clinical practice as a sensitive and specific marker of myocardial cellular necrosis. Objectives. The aim of our prospective study was to assess the presence of cTn-I in blood samples of patients with unstable angina and no signs of myocardial necrosis. Furthermore we intended to test the possible use of cTn-I in unstable angina as a prognostic marker of major coronary events on short and middle term. Methods. We studied 33 consecutive patients admitted to our CCU for unstable angina. According to unstable angina Braunwald's classification, 6 patients were included in the first class, 4 patients in the second class and 23 patients in the third class. We excluded patients with acute or recent myocardial infarction. Blood samples of all patients were obtained at the time of CCU admission and every eight hours in the first and second day. Serum cTn-I titration was performed with the sandwich immunoenzymometric method, recently introduced by Diagnostic Pasteur. Two months follow-up was carried out in order to survey major coronary events and revascularization procedures, either angioplasty or coronary artery bypass surgery. Results. No patients with unstable angina exhibited cTn-I in their blood samples; accordingly, cTn-I was not found in the first blood sample of a patient who undervent myocardial infarction during hospitalization. During the follow-up 2 patients died of myocardial infarction, 9 patients had surgical revascularization and 5 patients angioplasty. Conclusions. CTn-I is a sensitive and specific marker of myocardial necrosis. It is not found in patients with unstable angina; therefore it has no role as a prognostic marker of major coronary events.",
keywords = "Angina, unstable, Troponin i cardiac",
author = "P. Musso and A. Vernocchi and A. Crippa and D. Bajardi and B. Ottello and A. Pinnavaia and G. Ronzani and G. Bergandi and A. Ravera and I. Scrocca",
year = "1996",
month = "4",
language = "Italian",
volume = "44",
pages = "187--195",
journal = "Minerva Cardioangiologica",
issn = "0026-4725",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - La troponina I cardiaca nell'angina instabile

AU - Musso, P.

AU - Vernocchi, A.

AU - Crippa, A.

AU - Bajardi, D.

AU - Ottello, B.

AU - Pinnavaia, A.

AU - Ronzani, G.

AU - Bergandi, G.

AU - Ravera, A.

AU - Scrocca, I.

PY - 1996/4

Y1 - 1996/4

N2 - Background. Unstable angina implies high risk of myocardial infarction and sudden death. Increased levels of cytoplasmatic enzymes and proteins (creatine phosphokinase, MB creatine phosphokinase troponin T, etc.) were described in unstable angina, providing information about incoming major coronary events. Cardiac troponin I (cTn-I) is a structural protein inhibiting the actinomyosine ATPase; it is only found in myocardial cells. Serum titration of cTn-I has been recently introduced into clinical practice as a sensitive and specific marker of myocardial cellular necrosis. Objectives. The aim of our prospective study was to assess the presence of cTn-I in blood samples of patients with unstable angina and no signs of myocardial necrosis. Furthermore we intended to test the possible use of cTn-I in unstable angina as a prognostic marker of major coronary events on short and middle term. Methods. We studied 33 consecutive patients admitted to our CCU for unstable angina. According to unstable angina Braunwald's classification, 6 patients were included in the first class, 4 patients in the second class and 23 patients in the third class. We excluded patients with acute or recent myocardial infarction. Blood samples of all patients were obtained at the time of CCU admission and every eight hours in the first and second day. Serum cTn-I titration was performed with the sandwich immunoenzymometric method, recently introduced by Diagnostic Pasteur. Two months follow-up was carried out in order to survey major coronary events and revascularization procedures, either angioplasty or coronary artery bypass surgery. Results. No patients with unstable angina exhibited cTn-I in their blood samples; accordingly, cTn-I was not found in the first blood sample of a patient who undervent myocardial infarction during hospitalization. During the follow-up 2 patients died of myocardial infarction, 9 patients had surgical revascularization and 5 patients angioplasty. Conclusions. CTn-I is a sensitive and specific marker of myocardial necrosis. It is not found in patients with unstable angina; therefore it has no role as a prognostic marker of major coronary events.

AB - Background. Unstable angina implies high risk of myocardial infarction and sudden death. Increased levels of cytoplasmatic enzymes and proteins (creatine phosphokinase, MB creatine phosphokinase troponin T, etc.) were described in unstable angina, providing information about incoming major coronary events. Cardiac troponin I (cTn-I) is a structural protein inhibiting the actinomyosine ATPase; it is only found in myocardial cells. Serum titration of cTn-I has been recently introduced into clinical practice as a sensitive and specific marker of myocardial cellular necrosis. Objectives. The aim of our prospective study was to assess the presence of cTn-I in blood samples of patients with unstable angina and no signs of myocardial necrosis. Furthermore we intended to test the possible use of cTn-I in unstable angina as a prognostic marker of major coronary events on short and middle term. Methods. We studied 33 consecutive patients admitted to our CCU for unstable angina. According to unstable angina Braunwald's classification, 6 patients were included in the first class, 4 patients in the second class and 23 patients in the third class. We excluded patients with acute or recent myocardial infarction. Blood samples of all patients were obtained at the time of CCU admission and every eight hours in the first and second day. Serum cTn-I titration was performed with the sandwich immunoenzymometric method, recently introduced by Diagnostic Pasteur. Two months follow-up was carried out in order to survey major coronary events and revascularization procedures, either angioplasty or coronary artery bypass surgery. Results. No patients with unstable angina exhibited cTn-I in their blood samples; accordingly, cTn-I was not found in the first blood sample of a patient who undervent myocardial infarction during hospitalization. During the follow-up 2 patients died of myocardial infarction, 9 patients had surgical revascularization and 5 patients angioplasty. Conclusions. CTn-I is a sensitive and specific marker of myocardial necrosis. It is not found in patients with unstable angina; therefore it has no role as a prognostic marker of major coronary events.

KW - Angina, unstable

KW - Troponin i cardiac

UR - http://www.scopus.com/inward/record.url?scp=0030119197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030119197&partnerID=8YFLogxK

M3 - Articolo

C2 - 8767600

AN - SCOPUS:0030119197

VL - 44

SP - 187

EP - 195

JO - Minerva Cardioangiologica

JF - Minerva Cardioangiologica

SN - 0026-4725

IS - 4

ER -